Skip to main content

TEPA augments the ex-vivo and in-vivo potential of cord blood derived CD34+cells: From basic science to clinical trials.

Publication ,  Conference
Peled, T; Rubinstein, P; Kurtzberg, J; Nagler, A; Fibach, E; Shpall, EJ
Published in: BLOOD
November 16, 2003

Duke Scholars

Published In

BLOOD

ISSN

0006-4971

Publication Date

November 16, 2003

Volume

102

Issue

11

Start / End Page

961A / 961A

Location

SAN DIEGO, CALIFORNIA

Publisher

AMER SOC HEMATOLOGY

Conference Name

45th Annual Meeting of the American-Society-of-Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Peled, T., Rubinstein, P., Kurtzberg, J., Nagler, A., Fibach, E., & Shpall, E. J. (2003). TEPA augments the ex-vivo and in-vivo potential of cord blood derived CD34+cells: From basic science to clinical trials. In BLOOD (Vol. 102, pp. 961A-961A). SAN DIEGO, CALIFORNIA: AMER SOC HEMATOLOGY.
Peled, T., P. Rubinstein, J. Kurtzberg, A. Nagler, E. Fibach, and E. J. Shpall. “TEPA augments the ex-vivo and in-vivo potential of cord blood derived CD34+cells: From basic science to clinical trials.” In BLOOD, 102:961A-961A. AMER SOC HEMATOLOGY, 2003.
Peled T, Rubinstein P, Kurtzberg J, Nagler A, Fibach E, Shpall EJ. TEPA augments the ex-vivo and in-vivo potential of cord blood derived CD34+cells: From basic science to clinical trials. In: BLOOD. AMER SOC HEMATOLOGY; 2003. p. 961A-961A.
Peled, T., et al. “TEPA augments the ex-vivo and in-vivo potential of cord blood derived CD34+cells: From basic science to clinical trials.BLOOD, vol. 102, no. 11, AMER SOC HEMATOLOGY, 2003, pp. 961A-961A.
Peled T, Rubinstein P, Kurtzberg J, Nagler A, Fibach E, Shpall EJ. TEPA augments the ex-vivo and in-vivo potential of cord blood derived CD34+cells: From basic science to clinical trials. BLOOD. AMER SOC HEMATOLOGY; 2003. p. 961A-961A.

Published In

BLOOD

ISSN

0006-4971

Publication Date

November 16, 2003

Volume

102

Issue

11

Start / End Page

961A / 961A

Location

SAN DIEGO, CALIFORNIA

Publisher

AMER SOC HEMATOLOGY

Conference Name

45th Annual Meeting of the American-Society-of-Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology